MBXBF (Microbix Biosystems) YoY EPS Growth: 50.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MBXBF Microbix Biosystems Inc MBXBF
54 GF Score
Price $0.22
GF Value $0.16
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Microbix Biosystems YoY EPS Growth?

Microbix Biosystems MBXBF 54 YoY EPS Growth is 50.00% as of Jun. 2026. GuruFocus rates MBXBF with a GF Score™ of 54/100 and a GF Value™ of $0.16 (Significantly Overvalued). The stock has 8 warning signs investors should review.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Microbix Biosystems's YoY EPS Growth for the quarter that ended in Jun. 2026 was 50.00%.

Microbix Biosystems's Earnings per Share (Diluted) for the three months ended in Jun. 2026 was $-0.00.

Microbix Biosystems YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for Microbix Biosystems's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbix Biosystems YoY EPS Growth Chart

Microbix Biosystems Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 146.71 -51.94 -102.02 9,500.00 -161.17

Microbix Biosystems Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -746.15 -420.83 -233.33 -7,600.00 50.00
MBXBF
54GF Score
Microbix Biosystems Inc MBXBF
YoY EPS Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Microbix Biosystems YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Microbix Biosystems's YoY EPS Growth for the fiscal year that ended in Sep. 2025 is calculated as:

YoY EPS Growth (A: Sep. 2025 )
=(Earnings per Share (Diluted) (A: Sep. 2025 )-Earnings per Share (Diluted) (A: Sep. 2024 ))/ | Earnings per Share (Diluted) (A: Sep. 2024 ) |
=(-0.0115-0.0188)/ | 0.0188 |
=-161.17 %

Microbix Biosystems's YoY EPS Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EPS Growth (Q: Jun. 2026 )
=(Earnings per Share (Diluted) (Q: Jun. 2026 )-Earnings per Share (Diluted) (Q: Jun. 2025 )) / | Earnings per Share (Diluted) (Q: Jun. 2025 )) |
=(-0.0042--0.0084)/ | -0.0084 |
=50.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 50.00% mean?
Microbix Biosystems (MBXBF) has a YoY EPS Growth of 50.00% as of Jun. 2026. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Microbix Biosystems and its competitors.
Is Microbix Biosystems' YoY EPS Growth too high?
Microbix Biosystems' current YoY EPS Growth is 50.00%. Overall, Microbix Biosystems has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Microbix Biosystems' YoY EPS Growth compare to VRTX and REGN?
Microbix Biosystems' YoY EPS Growth of 50.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Biotechnology company?
A good YoY EPS Growth depends on the Biotechnology industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Microbix Biosystems and its competitors. Microbix Biosystems's current YoY EPS Growth is 50.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbix Biosystems stock overvalued right now?
Based on GuruFocus' analysis, Microbix Biosystems (MBXBF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.16, compared to a current price of $0.22 — trading 36.3% above its estimated fair value. The current YoY EPS Growth is 50.00%. Microbix Biosystems' overall GF Score™ is 54/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For Microbix Biosystems (MBXBF), the current YoY EPS Growth is 50.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Microbix Biosystems (MBXBF) Overvalued in 2026?

Based on GuruFocus' analysis, Microbix Biosystems stock appears to be overvalued. The current stock price of $0.22 is trading 36.3% above its estimated GF Value™ of $0.16. GuruFocus considers Microbix Biosystems to be Significantly Overvalued.

Key valuation signals for MBXBF:

  • YoY EPS Growth: 50.00%
  • GF Value™: $0.16 vs. price of $0.22 (36.3% above fair value)
  • GF Score™: 54/100 with 8 warning signs

No single metric tells the full story. See the MBXBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Microbix Biosystems Business Description

Other Exchanges MBX:Canada
Address 265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows, and viral transport medium to enable collection of patient test samples; and the development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.
54GF Score

Get the complete analysis for MBXBF

YoY EPS Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.22
Price
$0.16
GF Value